News
Working to stop the spread of breast cancer
Spartans are unveiling and studying chemical clues that could lead to better diagnoses and treatments for a metastatic form of breast cancer with support from a $2 million NIH grant
Michigan State researchers are revealing the molecular workings of how a certain form of metastatic breast cancer spreads to other parts of the body. In doing so, they’re creating new opportunities to spot and contain what is called triple negative breast cancer.
Facility for Rare Isotope Beams opens its doors to discovery
Michigan State University’s Facility for Rare Isotope Beams (FRIB), a user facility for the U.S. Department of Energy Office of Science, opened its doors to discovery with a ribbon-cutting ceremony on 2 May. U.S. Secretary of Energy Jennifer M. Granholm and MSU President Samuel L. Stanley Jr., M.D., cut the ribbon to officially mark the start of FRIB’s scientific mission.
“Returning home to Michigan to unveil the FRIB—which began construction when I was Governor—is a testament to the hard work that it took to get to this point and the pivotal role this facility will play in making America the global leader in rare isotope nuclear science research,” said U.S. Secretary of Energy Jennifer M. Granholm. “Along with boosting the nation’s innovative capacity and global competitiveness, this facility will help us discover new things about our universe and ourselves, find new ways to diagnose and treat cancer, and strengthen our national security.”
DO-PhD student’s cancer research shows promising results
Helping patients gain valuable time with loved ones is the major reason why sixth year D.O.-Ph.D. student at Michigan State University College of Osteopathic Medicine, Lyndsey Reich, wanted to become a researcher and a physician.
Reich’s father was involved in multiple clinical trials that extended his life by about 10 years, which allowed her to see the immediate impact research can have for patients. Remembering the important gift of time her father received while participating in trials during his illness prompted her to choose the path of medicine and research.